Overview

Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.

Status:
RECRUITING

Trial end date:
2027-07-31

Target enrollment:

Participant gender:

Summary

Phase II clinical study of irinotecan liposome (II)-based combination regimen as a treatment for irinotecan-resistant colorectal cancer.

Phase:

PHASE2

Details

Lead Sponsor:

Chinese PLA General Hospital